España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Coeptis Therapeutics
COEP
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.1415
-0.00300
-2.08%
At close: -
$0.1470
0.00550
3.89%
After Hours: Dec 20, 5:21 PM EDT
Get Report
Comment
Coeptis Therapeutics (COEP) Forecast
News
Earnings
Coeptis Therapeutics (COEP) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Coeptis Therapeutics (NASDAQ:COEP) Stock
Coeptis Therapeutics Stock (NASDAQ: COEP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 12, 2024
Coeptis Therapeutics shares are trading highe...
Benzinga Newsdesk
Coeptis Therapeutics Holdings Announces The L...
Benzinga Newsdesk
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, December 03, 2024
Coeptis Therapeutics Signs Binding Letter Of ...
Benzinga Newsdesk
Thursday, November 07, 2024
Coeptis Therapeutics Announces Phase 1 Data O...
Benzinga Newsdesk
Thursday, October 24, 2024
Coeptis Therapeutics Expands License Agreemen...
Benzinga Newsdesk
Thursday, September 19, 2024
Coeptis Therapeutics Receives Notification Le...
Benzinga Newsdesk
Thursday, September 05, 2024
Coeptis Therapeutics CEO Updates Shareholders...
Benzinga Newsdesk
Thursday, August 08, 2024
Why Digital Turbine Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, May 22, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Wednesday, May 08, 2024
Coeptis Therapeutics To Present Universal All...
Benzinga Newsdesk
Thursday, April 04, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Tuesday, March 26, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Thursday, March 14, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Monday, February 26, 2024
Coeptis Therapeutics Adds Autoimmune Indicati...
Benzinga Newsdesk
Monday, February 12, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Thursday, February 08, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, February 07, 2024
Coeptis Therapeutics Plans To Pursue DVX201, ...
Benzinga Newsdesk
Thursday, January 18, 2024
Collective Audience And 3 Other Stocks Under $1 Insiders Are Buying
Avi Kapoor
Wednesday, January 17, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Thursday, January 04, 2024
Coeptis Therapeutics Sets Sights on Expanding...
Benzinga Newsdesk
Tuesday, October 31, 2023
Coeptis Therapeutics Announces Research Demon...
Benzinga Newsdesk
Wednesday, October 11, 2023
Coeptis Therapeutics Has Expanded Its Exclusi...
Benzinga Newsdesk
Thursday, September 28, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Friday, September 22, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
Benzinga Insights
Ladenburg Thalmann Initiates Coverage On Coep...
Benzinga Newsdesk
Thursday, September 14, 2023
Coeptis Therapeutics' Phase 1 Trials Of DVX20...
Benzinga Newsdesk
Monday, September 11, 2023
Coeptis Therapeutics' Partner Deverra Therape...
Benzinga Newsdesk
Friday, September 01, 2023
BioRestorative Therapies And 3 Other Stocks Under $3 Insiders Are Buying
Lisa Levin
Tuesday, August 22, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, August 17, 2023
Coeptis Therapeutics Has Completed The Exclus...
Benzinga Newsdesk
Tuesday, August 01, 2023
Coeptis Therapeutics Files FDA 513(g) Submiss...
Benzinga Newsdesk
Thursday, July 13, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Tuesday, July 04, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Wednesday, June 14, 2023
Coeptis Therapeutics Holdings, Inc. Announces...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Why Inventiva Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Thursday, June 08, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Monday, June 05, 2023
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Thursday, May 25, 2023
EF Hutton Assumes Coeptis Therapeutics at Buy...
Benzinga Newsdesk
Thursday, May 18, 2023
EF Hutton Reiterates Buy on Coeptis Therapeut...
Benzinga Newsdesk
Wednesday, May 17, 2023
Coeptis Therapeutics Appoints Brian Cogley As Chief Financial Officer
Happy Mohamed
Wednesday, May 10, 2023
EF Hutton Reiterates Buy on Coeptis Therapeut...
Benzinga Newsdesk
Wednesday, April 19, 2023
Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023
Benzinga Insights
JonesTrading Initiates Coverage On Coeptis Th...
Benzinga Newsdesk
Tuesday, April 18, 2023
Coeptis Has Entered Into Binding Term Sheet F...
Benzinga Newsdesk
Wednesday, April 05, 2023
EF Hutton Reiterates Buy on Coeptis Therapeut...
Benzinga Newsdesk
Wednesday, March 29, 2023
EF Hutton Reiterates Buy on Coeptis Therapeut...
Benzinga Newsdesk
Coeptis Therapeutics Secures Exclusive Rights To Negotiate To Acquire Transformational Cell Therapy Platform To Enable Potent Combinatorial Immuno-Oncology Treatment Strategies
Happy Mohamed
Monday, March 27, 2023
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch